Delivery Order SPE2DB24D2205-SPE2DB25FECVS
Award Date 5/27/25
Potential Completion Date 6/17/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pens on May 6, 2025, with completion scheduled for May 28, 2025. This firm fixed-price, competitively awarded order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pens on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tezspire is a specialized biologic medication used in the treatment of...
- The Defense Logistics Agency awarded a $4,939.58 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Tezspire 210 mg/1.91 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 17, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This non-competitive delivery order, with a firm fixed price structure, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tezspire is a specialty biologic medication used in the treatment of severe asthma, reflecting the...
- The Defense Logistics Agency awarded a $14,818.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injectables on November 12, 2025, with completion targeted for December 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and reflects...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,687.18 for Tezspire 210 mg/1.91 mL pen injectors, with a completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Tezspire is a specialty biologic medication used in the treatment of severe asthma, representing the type of high-value...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $14,061.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), carries an ultimate completion date of September 3, 2025, and involves no set-aside designation....
- The Defense Logistics Agency awarded a $9,374.36 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pens on July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order is unset-aside and competitively awarded, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Tezspire is a monoclonal antibody biologic used in asthma and chronic rhinosinusitis treatment, representing part of...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen injectors on August 8, 2025, with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract was issued under a competitive procurement process and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Tezspire is a biologic medication used in the treatment of moderate-to-severe asthma, representing the type of...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The products will be performed at AmerisourceBergen's corporate office location in...